Farmers & Merchants Trust Co of Chambersburg PA lessened its position in Johnson & Johnson (NYSE:JNJ) by 2.1% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 29,435 shares of the company’s stock after selling 631 shares during the period. Johnson & Johnson makes up 3.3% of Farmers & Merchants Trust Co of Chambersburg PA’s investment portfolio, making the stock its 2nd largest holding. Farmers & Merchants Trust Co of Chambersburg PA’s holdings in Johnson & Johnson were worth $3,827,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in JNJ. Harding Loevner LP purchased a new position in shares of Johnson & Johnson in the 2nd quarter valued at about $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in shares of Johnson & Johnson by 29.9% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after purchasing an additional 200 shares in the last quarter. Lenox Wealth Advisors Inc. increased its holdings in shares of Johnson & Johnson by 0.6% in the 2nd quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after purchasing an additional 5 shares in the last quarter. Mountain Capital Investment Advisors Inc purchased a new position in shares of Johnson & Johnson in the 2nd quarter valued at about $124,000. Finally, Shine Investment Advisory Services Inc. purchased a new position in shares of Johnson & Johnson in the 2nd quarter valued at about $177,000. Institutional investors own 65.70% of the company’s stock.
A number of equities analysts have recently issued reports on JNJ shares. Credit Suisse Group set a $154.00 price target on shares of Johnson & Johnson and gave the company an “outperform” rating in a report on Thursday, October 19th. Royal Bank of Canada increased their price target on shares of Johnson & Johnson from $144.00 to $147.00 and gave the company an “outperform” rating in a report on Wednesday, October 18th. Vetr downgraded shares of Johnson & Johnson from a “buy” rating to a “hold” rating and set a $146.35 target price for the company. in a report on Friday, December 22nd. Citigroup initiated coverage on shares of Johnson & Johnson in a report on Monday, September 25th. They set a “neutral” rating and a $140.00 target price for the company. Finally, Goldman Sachs Group downgraded shares of Johnson & Johnson from a “neutral” rating to a “sell” rating and raised their target price for the company from $125.00 to $130.00 in a report on Wednesday, September 20th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $145.47.
Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, October 17th. The company reported $1.90 EPS for the quarter, topping analysts’ consensus estimates of $1.80 by $0.10. The business had revenue of $19.65 billion during the quarter, compared to the consensus estimate of $19.29 billion. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.68 earnings per share. equities research analysts anticipate that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Tuesday, November 28th were issued a dividend of $0.84 per share. The ex-dividend date was Monday, November 27th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.40%. Johnson & Johnson’s dividend payout ratio (DPR) is presently 58.33%.
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.com-unik.info/2017/12/27/farmers-merchants-trust-co-of-chambersburg-pa-has-3-83-million-stake-in-johnson-johnson-jnj.html.
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.